Competition for Assura is Growing in Connection with the Investigation

• KKR has called on the Assura board to support its proposal
• PHP has been blocked from integrating with Assura due to the investigation
• Assura owns over 600 medical facilities in Great Britain

The competition for NHS provider Assura is intensifying, as the American private investment firm KKR has called on the company's board to support its proposal, having withdrawn from supporting competitor PHP. This occurred against the backdrop of the ongoing investigation by the UK competition regulator, which began the investigation into the agreement.

PHP, a company that specializes in investments in building medical practices, received support from the Assura board in red for the agreement worth £1.79 billion. However, KKR and Stonepeak are leading their own campaign against Assura, proposing a lower cash offer of £1.7 billion.

The competition and increasing pressure from the regulator have led KKR to consider its proposal more attractive due to the lower price of the shares of both companies. KKR asserts that their proposal does not carry the risks associated with an antitrust nature and could ensure better growth for Assura.

Assura owns more than 600 facilities, including clinics and medical practices, and has a market value of approximately £3.1 billion. Over the past year, the company secured a revenue increase from operations of 16.6%, which translated into a profit of £166 million.

Tags: Europe/Economy